Target intelligence / Profile preview

Varroa destructor octopamine receptor alpha-2 (VdOctα2R)

Target
VdOctα2R
Molecular classification
G protein-coupled receptor, Biogenic amine receptor, Octopamine receptor
01

Overview

Varroa destructor octopamine receptor alpha-2 (VdOctα2R) is a G protein-coupled receptor (GPCR) that plays a vital role in the neurophysiology of the honey bee ectoparasitic mite, Varroa destructor (Blenau et al., 2013). As an alpha-adrenergic-like receptor, it is primarily activated by octopamine, which is the invertebrate functional analog of norepinephrine (Farooqui, 2012). This receptor is involved in modulating essential biological functions such as motor activity, sensory processing, and reproductive behaviors within the mite (Wu et al., 2021). Given its central role in the mite's nervous system and its divergence from vertebrate receptors, VdOctα2R is a significant target for acaricides designed to control Varroa infestations in apiculture (Ozoe, 2013). Chemical agents that interact with this receptor, including various formamidines and experimental biogenic amine analogs, can cause lethal overstimulation or neurological interference (Gross et al., 2017). However, the development of resistance to traditional acaricides and the need for honey bee safety necessitate the discovery of highly selective ligands that target VdOctα2R without affecting the host's own octopaminergic system (Blenau & Thamm, 2011).

Other names
VdOctalpha2ROctopamine alpha-2 receptorAlpha-adrenergic-like octopamine receptorVarroa destructor octopamine receptor alpha-2-like
02

Mechanism of action

Agonism or antagonism of the receptor disrupts biogenic amine signaling in the mite's central nervous system, leading to physiological dysfunction, paralysis, or death.

03

Biological functions

Signal transductionNeuromodulationLocomotionReproductionSensory processing
04

Disease associations

InfectionParasitic infestation
05

Safety considerations

Cross-reactivity with honey bee octopamine receptorsDevelopment of acaricide resistanceEnvironmental toxicityPotential off-target effects on non-target invertebrates
06

Interacting drugs

Octopamine

7 more in the full profile.

07

Biomarkers

Mite mortalityReceptor mRNA expression levels

Beyond the preview

Go deeper on Varroa destructor octopamine receptor alpha-2 (VdOctα2R).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Varroa destructor octopamine receptor alpha-2 (VdOctα2R).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call